Latest News
ABL Diagnostics secures clinical research contract worth up to EUR2.7m through 2031
12 June 2026 - ABL Diagnostics (Euronext Paris:ABLD), a provider of molecular biology tests, announced on Friday that it has signed a multi-year contract with a European pharmaceutical company focused on neurodegenerative diseases for services provid...
Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study
12 June 2026 - Airiver Medical, a clinical stage company developing technologies to help patients with certain respiratory tract conditions, announced on Thursday the successful treatment of the first patient with chronic rhinosinusitis (CRS) in its ...
WeNatal introduces Iron+ iron and vitamin C supplement
12 June 2026 - Prenatal supplement and lifestyle brand WeNatal announced on Thursday the launch of Iron+, a targeted iron and vitamin C supplement formulated for moments when additional iron support may be beneficial or recommended.According to the c...
Precigen and the RRPF recognise International RRP Awareness Day
12 June 2026 - Commercial-stage biopharmaceutical company Precigen Inc (Nasdaq:PGEN) and the Recurrent Respiratory Papillomatosis Foundation (RRPF) announced on Thursday their continued collaboration in recognition of the third annual International R...
Roche secures IVDR approval to expand VENTANA MMR RxDx Panel indications
...